World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
Italy
2026

D-Index & Metrics

Best Scientists

D-Index
171
Citations
158597
World Ranking
820
National Ranking
10

Medicine

D-Index
175
Citations
164056
World Ranking
421
National Ranking
7

Research.com Recognitions

  • 2026 - Research.com Medicine in Italy Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Italy Leader Award
  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Aldo P. Maggioni is affiliated with the Heart Care Foundation and the ANMCO Research Center in Florence, Italy. Their research primarily spans the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine.

The scientist has contributed extensively to several subfields including Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, and Epidemiology.

Their work addresses key topics such as Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Health Systems, Economic Evaluations, Quality of Life, Atrial Fibrillation Management and Outcomes, Cardiac pacing and defibrillation studies, Acute Myocardial Infarction Research, and Diabetes Treatment and Management.

Notable recent papers by Aldo P. Maggioni include:

  • Initial Invasive or Conservative Strategy for Stable Coronary Disease, 2020, New England Journal of Medicine
  • Empagliflozin in Patients with Chronic Kidney Disease, 2022, New England Journal of Medicine
  • European Society of Cardiology: cardiovascular disease statistics 2021, 2021, European Heart Journal
  • Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology, 2020, European Heart Journal - Quality of Care and Clinical Outcomes
  • Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT), 2020, European Heart Journal

Aldo P. Maggioni collaborates frequently with several researchers, including Luigi Tavazzi, John J.V. McMurray, Chris P Gale, Cécile Laroche, and Scott D. Solomon.

The researcher often publishes in a variety of venues, with the most frequent among them being:

  • European Heart Journal
  • PubMed
  • European Journal of Heart Failure
  • European Heart Journal - Quality of Care and Clinical Outcomes
  • International Journal of Cardiology

Best Publications

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

    Stamatis Adamopoulos;Stefan D. Anker;Volkmar Falk;Lars Køber

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

    Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • The Seattle Heart Failure Model Prediction of Survival in Heart Failure

    Wayne C. Levy;Dariush Mozaffarian;David T. Linker;Santosh C. Sutradhar

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Jean-Claude Tardif;Simon Kouz;David D. Waters;Olivier F. Bertrand

  • Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

    Roberto Marchioli;Federica Barzi;Elena Bomba;Carmine Chieffo

  • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

    Johannes F. E. Mann;Roland E Schmieder;Matthew McQueen;Leanne Dyal

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

    Rury R. Holman;M. Angelyn Bethel;Robert J. Mentz;Vivian P. Thompson

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Guidelines for the diagnosis and treatment of pulmonary hypertension

    Marius M. Hoeper;Marc Humbert;Adam Torbicki;Jean-Luc Vachiery

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

Frequent Co-Authors

Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Roberto Latini
Roberto Latini Mario Negri Institute for Pharmacological Research
Gianni Tognoni
Gianni Tognoni University of Milan
John J.V. McMurray
John J.V. McMurray University of Glasgow
Faiez Zannad
Faiez Zannad University of Lorraine
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Mihai Gheorghiade
Mihai Gheorghiade Northwestern University
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Lars Køber
Lars Køber Copenhagen University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options in medicine goes beyond becoming a doctor. Today, there are flexible online degrees and career pathways for those interested in healthcare, each offering unique advantages.

For individuals seeking administrative roles, healthcare administration degrees help you advance quickly through accelerated online programs, preparing you for leadership positions in medical settings. If you wish to get started in nursing but want to avoid traditional entrance exams, consider enrolling in a lpn school without teas test requirements for a smoother admission process.

Those interested in coding and office management in healthcare should look into colleges that provide financial aid for medical billing and coding degrees, making these programs more accessible. Additionally, registered nurses with an associate degree can accelerate their careers through asn to np programs, bridging to nurse practitioner roles in less time.

These diverse pathways open doors to rewarding healthcare careers without following the traditional medical school route.

Best Scientists Citing Aldo P. Maggioni

Trending Scientists